Therefore, we hypothesize that tumor-associated MSC-2 populations is the mediator of the bone remodeling observed in ccRCC bone metastasis patients through the channel of RANKL-RANK/OPG signaling. This evidence concerns the gene TNFRSF11A and neoplasm.